Personalized Psychiatry with Hans Eriksson
Future of Psychiatry! Innovations in Mental Health
Targeting the HPA Axis: New Advances in Depression Treatment
This chapter examines the development of innovative medications targeting the HPA axis to address stress-related dysregulation in depression. It highlights ongoing research into medications that block specific receptors, as well as a novel formulation of ketamine aimed at improving treatment outcomes for patients with major depressive disorder and treatment-resistant depression.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
